Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
In Situ Dark Adaptation Enhances the Efficiency of DNA Extraction from Mature Pin Oak (Quercus palustris) Leaves, Facilitating the Identification of Partial Sequences of the 18S rRNA and Isoprene Synthase (IspS) Genes.

Plants (Basel, Switzerland)

Barta CE, Bolander B, Bilby SR, Brown JH, Brown RN, Duryee AM, Edelman DR, Gray CE, Gossett C, Haddock AG, Helsel MM, Jones AD, Klingseis ME, Leslie K, Miles EW, Prawitz RA.
PMID: 29073736
Plants (Basel). 2017 Oct 24;6(4). doi: 10.3390/plants6040052.

Mature oak (

Cite
Barta CE, Bolander B, Bilby SR, et al. In Situ Dark Adaptation Enhances the Efficiency of DNA Extraction from Mature Pin Oak (Quercus palustris) Leaves, Facilitating the Identification of Partial Sequences of the 18S rRNA and Isoprene Synthase (IspS) Genes. Plants (Basel). 2017;6(4)doi: 10.3390/plants6040052.
Barta, C. E., Bolander, B., Bilby, S. R., Brown, J. H., Brown, R. N., Duryee, A. M., Edelman, D. R., Gray, C. E., Gossett, C., Haddock, A. G., Helsel, M. M., Jones, A. D., Klingseis, M. E., Leslie, K., Miles, E. W., & Prawitz, R. A. (2017). In Situ Dark Adaptation Enhances the Efficiency of DNA Extraction from Mature Pin Oak (Quercus palustris) Leaves, Facilitating the Identification of Partial Sequences of the 18S rRNA and Isoprene Synthase (IspS) Genes. Plants (Basel, Switzerland), 6(4), . https://doi.org/10.3390/plants6040052
Barta, Csengele E, et al. "In Situ Dark Adaptation Enhances the Efficiency of DNA Extraction from Mature Pin Oak (Quercus palustris) Leaves, Facilitating the Identification of Partial Sequences of the 18S rRNA and Isoprene Synthase (IspS) Genes." Plants (Basel, Switzerland) vol. 6,4 (2017). doi: https://doi.org/10.3390/plants6040052
Barta CE, Bolander B, Bilby SR, Brown JH, Brown RN, Duryee AM, Edelman DR, Gray CE, Gossett C, Haddock AG, Helsel MM, Jones AD, Klingseis ME, Leslie K, Miles EW, Prawitz RA. In Situ Dark Adaptation Enhances the Efficiency of DNA Extraction from Mature Pin Oak (Quercus palustris) Leaves, Facilitating the Identification of Partial Sequences of the 18S rRNA and Isoprene Synthase (IspS) Genes. Plants (Basel). 2017 Oct 24;6(4). doi: 10.3390/plants6040052. PMID: 29073736; PMCID: PMC5750628.
Copy Download .nbib Format: NLM
Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training.

Journal of the International Society of Sports Nutrition

Stark M, Lukaszuk J, Prawitz A, Salacinski A.
PMID: 23241341
J Int Soc Sports Nutr. 2012 Dec 14;9(1):54. doi: 10.1186/1550-2783-9-54.

The purpose of this review was to determine whether past research provides conclusive evidence about the effects of type and timing of ingestion of specific sources of protein by those engaged in resistance weight training. Two essential, nutrition-related, tenets...

Cite
Stark M, Lukaszuk J, Prawitz A, et al. Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training. J Int Soc Sports Nutr. 2012;9(1):54doi: 10.1186/1550-2783-9-54.
Stark, M., Lukaszuk, J., Prawitz, A., & Salacinski, A. (2012). Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training. Journal of the International Society of Sports Nutrition, 9(1), 54. https://doi.org/10.1186/1550-2783-9-54
Stark, Matthew, et al. "Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training." Journal of the International Society of Sports Nutrition vol. 9,1 (2012): 54. doi: https://doi.org/10.1186/1550-2783-9-54
Stark M, Lukaszuk J, Prawitz A, Salacinski A. Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training. J Int Soc Sports Nutr. 2012 Dec 14;9(1):54. doi: 10.1186/1550-2783-9-54. PMID: 23241341; PMCID: PMC3529694.
Copy Download .nbib Format: NLM
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Yu T, Bharmal M.
PMID: 34372979
Value Health. 2021 Aug;24(8):1137-1144. doi: 10.1016/j.jval.2021.03.004. Epub 2021 May 08.

OBJECTIVES: Population-adjusted comparisons of progression-free survival (PFS) from single-arm trials of cancer treatments can be derived using matching-adjusted indirect comparisons (MAICs); however, results are still susceptible to bias, particularly if the trials had different tumor assessment schedules. This study...

Cite
Kapetanakis V, Prawitz T, Schlichting M, et al. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value Health. 2021;24(8):1137-1144doi: 10.1016/j.jval.2021.03.004.
Kapetanakis, V., Prawitz, T., Schlichting, M., Ishak, K. J., Phatak, H., Yu, T., & Bharmal, M. (2021). How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(8), 1137-1144. https://doi.org/10.1016/j.jval.2021.03.004
Kapetanakis, Venediktos, et al. "How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 24,8 (2021): 1137-1144. doi: https://doi.org/10.1016/j.jval.2021.03.004
Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Yu T, Bharmal M. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value Health. 2021 Aug;24(8):1137-1144. doi: 10.1016/j.jval.2021.03.004. Epub 2021 May 08. PMID: 34372979.
Copy Download .nbib Format: NLM
A Model-Based fMRI Analysis with Hierarchical Bayesian Parameter Estimation.

Journal of neuroscience, psychology, and economics

Ahn WY, Krawitz A, Kim W, Busmeyer JR, Brown JW.
PMID: 23795233
J Neurosci Psychol Econ. 2011 May;4(2):95-110. doi: 10.1037/a0020684.

A recent trend in decision neuroscience is the use of model-based fMRI using mathematical models of cognitive processes. However, most previous model-based fMRI studies have ignored individual differences due to the challenge of obtaining reliable parameter estimates for individual...

Cite
Ahn WY, Krawitz A, Kim W, et al. A Model-Based fMRI Analysis with Hierarchical Bayesian Parameter Estimation. J Neurosci Psychol Econ. 2011;4(2):95-110doi: 10.1037/a0020684.
Ahn, W. Y., Krawitz, A., Kim, W., Busmeyer, J. R., & Brown, J. W. (2011). A Model-Based fMRI Analysis with Hierarchical Bayesian Parameter Estimation. Journal of neuroscience, psychology, and economics, 4(2), 95-110. https://doi.org/10.1037/a0020684
Ahn, Woo-Young, et al. "A Model-Based fMRI Analysis with Hierarchical Bayesian Parameter Estimation." Journal of neuroscience, psychology, and economics vol. 4,2 (2011): 95-110. doi: https://doi.org/10.1037/a0020684
Ahn WY, Krawitz A, Kim W, Busmeyer JR, Brown JW. A Model-Based fMRI Analysis with Hierarchical Bayesian Parameter Estimation. J Neurosci Psychol Econ. 2011 May;4(2):95-110. doi: 10.1037/a0020684. PMID: 23795233; PMCID: PMC3686299.
Copy Download .nbib Format: NLM
Repeatability of endocrine traits and dominance rank in female guinea pigs.

Frontiers in zoology

Rystrom TL, Prawitt RC, Richter SH, Sachser N, Kaiser S.
PMID: 35031061
Front Zool. 2022 Jan 14;19(1):4. doi: 10.1186/s12983-021-00449-2.

BACKGROUND: Glucocorticoids (e.g. cortisol) are associated with variation in social behavior, and previous studies have linked baseline as well as challenge-induced glucocorticoid concentrations to dominance status. It is known that cortisol response to an acute challenge is repeatable and...

Cite
Rystrom TL, Prawitt RC, Richter SH, et al. Repeatability of endocrine traits and dominance rank in female guinea pigs. Front Zool. 2022;19(1):4doi: 10.1186/s12983-021-00449-2.
Rystrom, T. L., Prawitt, R. C., Richter, S. H., Sachser, N., & Kaiser, S. (2022). Repeatability of endocrine traits and dominance rank in female guinea pigs. Frontiers in zoology, 19(1), 4. https://doi.org/10.1186/s12983-021-00449-2
Rystrom, Taylor L, et al. "Repeatability of endocrine traits and dominance rank in female guinea pigs." Frontiers in zoology vol. 19,1 (2022): 4. doi: https://doi.org/10.1186/s12983-021-00449-2
Rystrom TL, Prawitt RC, Richter SH, Sachser N, Kaiser S. Repeatability of endocrine traits and dominance rank in female guinea pigs. Front Zool. 2022 Jan 14;19(1):4. doi: 10.1186/s12983-021-00449-2. PMID: 35031061.
Copy Download .nbib Format: NLM
Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment.

Journal of clinical epidemiology

Tervonen T, Prawitz T, Chua GN, Hyacinthe J, Pinto CA.
PMID: 34856367
J Clin Epidemiol. 2021 Nov 29; doi: 10.1016/j.jclinepi.2021.11.036. Epub 2021 Nov 29.

OBJECTIVE: To assess the effect of patient preferences on the net clinical benefit (NCB) of an antiplatelet therapy for the secondary prevention of cardiovascular complications.STUDY DESIGN AND SETTING: Risk equations were developed to estimate the individual predicted risk of...

Cite
Tervonen T, Prawitz T, Chua GN, et al. Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. J Clin Epidemiol. 2021;doi: 10.1016/j.jclinepi.2021.11.036.
Tervonen, T., Prawitz, T., Chua, G. N., Hyacinthe, J., & Pinto, C. A. (2021). Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. Journal of clinical epidemiology, . https://doi.org/10.1016/j.jclinepi.2021.11.036
Tervonen, Tommi, et al. "Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment." Journal of clinical epidemiology vol. (2021). doi: https://doi.org/10.1016/j.jclinepi.2021.11.036
Tervonen T, Prawitz T, Chua GN, Hyacinthe J, Pinto CA. Net clinical benefit of antiplatelet therapy was affected by patient preferences: A personalized benefit-risk assessment. J Clin Epidemiol. 2021 Nov 29; doi: 10.1016/j.jclinepi.2021.11.036. Epub 2021 Nov 29. PMID: 34856367.
Copy Download .nbib Format: NLM
Repeatability of endocrine traits and dominance rank in female guinea pigs.

Frontiers in zoology

Rystrom TL, Prawitt RC, Richter SH, Sachser N, Kaiser S.
PMID: 35031061
Front Zool. 2022 Jan 14;19(1):4. doi: 10.1186/s12983-021-00449-2.

BACKGROUND: Glucocorticoids (e.g. cortisol) are associated with variation in social behavior, and previous studies have linked baseline as well as challenge-induced glucocorticoid concentrations to dominance status. It is known that cortisol response to an acute challenge is repeatable and...

Cite
Rystrom TL, Prawitt RC, Richter SH, et al. Repeatability of endocrine traits and dominance rank in female guinea pigs. Front Zool. 2022;19(1):4doi: 10.1186/s12983-021-00449-2.
Rystrom, T. L., Prawitt, R. C., Richter, S. H., Sachser, N., & Kaiser, S. (2022). Repeatability of endocrine traits and dominance rank in female guinea pigs. Frontiers in zoology, 19(1), 4. https://doi.org/10.1186/s12983-021-00449-2
Rystrom, Taylor L, et al. "Repeatability of endocrine traits and dominance rank in female guinea pigs." Frontiers in zoology vol. 19,1 (2022): 4. doi: https://doi.org/10.1186/s12983-021-00449-2
Rystrom TL, Prawitt RC, Richter SH, Sachser N, Kaiser S. Repeatability of endocrine traits and dominance rank in female guinea pigs. Front Zool. 2022 Jan 14;19(1):4. doi: 10.1186/s12983-021-00449-2. PMID: 35031061.
Copy Download .nbib Format: NLM
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Yu T, Bharmal M.
PMID: 34372979
Value Health. 2021 Aug;24(8):1137-1144. doi: 10.1016/j.jval.2021.03.004. Epub 2021 May 08.

OBJECTIVES: Population-adjusted comparisons of progression-free survival (PFS) from single-arm trials of cancer treatments can be derived using matching-adjusted indirect comparisons (MAICs); however, results are still susceptible to bias, particularly if the trials had different tumor assessment schedules. This study...

Cite
Kapetanakis V, Prawitz T, Schlichting M, et al. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value Health. 2021;24(8):1137-1144doi: 10.1016/j.jval.2021.03.004.
Kapetanakis, V., Prawitz, T., Schlichting, M., Ishak, K. J., Phatak, H., Yu, T., & Bharmal, M. (2021). How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 24(8), 1137-1144. https://doi.org/10.1016/j.jval.2021.03.004
Kapetanakis, Venediktos, et al. "How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 24,8 (2021): 1137-1144. doi: https://doi.org/10.1016/j.jval.2021.03.004
Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Yu T, Bharmal M. How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments. Value Health. 2021 Aug;24(8):1137-1144. doi: 10.1016/j.jval.2021.03.004. Epub 2021 May 08. PMID: 34372979.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries